Created at Source Raw Value Validated value
Nov. 16, 2021, 6:30 p.m. usa

patients requiring immediate admission to the icu, patients requiring invasive mechanical ventilation, ards of another origin, concomitant pulmonary infection (pneumoniae) with another agent, notably bacterial or fungal, patients under immunosuppressive agents, childbirth within <10 days, pregnancy or breastfeeding, prior cardiopulmonary resuscitation <10 days, allergy or hypersensitivity to drugs of the same class participation in another interventional clinical trial within 30 days prior to the inclusion.

patients requiring immediate admission to the icu, patients requiring invasive mechanical ventilation, ards of another origin, concomitant pulmonary infection (pneumoniae) with another agent, notably bacterial or fungal, patients under immunosuppressive agents, childbirth within <10 days, pregnancy or breastfeeding, prior cardiopulmonary resuscitation <10 days, allergy or hypersensitivity to drugs of the same class participation in another interventional clinical trial within 30 days prior to the inclusion.

Dec. 11, 2020, 12:31 a.m. usa

1. patients requiring immediate admission to the icu, 2. patients requiring invasive mechanical ventilation, 3. ards of another origin, 4. concomitant pulmonary infection (pneumoniae) with another agent, notably bacterial or fungal, 5. patients under immunosuppressive agents, 6. childbirth within <10 days, 7. pregnancy or breastfeeding, 8. prior cardiopulmonary resuscitation <10 days, 9. allergy or hypersensitivity to drugs of the same class 10. participation in another interventional clinical trial within 30 days prior to the inclusion.

1. patients requiring immediate admission to the icu, 2. patients requiring invasive mechanical ventilation, 3. ards of another origin, 4. concomitant pulmonary infection (pneumoniae) with another agent, notably bacterial or fungal, 5. patients under immunosuppressive agents, 6. childbirth within <10 days, 7. pregnancy or breastfeeding, 8. prior cardiopulmonary resuscitation <10 days, 9. allergy or hypersensitivity to drugs of the same class 10. participation in another interventional clinical trial within 30 days prior to the inclusion.